可纳类型和衍生物:合成,化学转化和生物活动的概述
Michał Janowski1, Oleg M Demchuk2, Monika Wujec3
1Doctoral School, Medical University of Lublin, Chodzki 7, 20-093 Lublin, Poland.
Molecules (Basel, Switzerland)
|June 27, 2024
概括
研究人员合成了新型的可纳衍生物来对抗日益增长的抗真菌耐药性. 这些修改后的分子旨在改善对抗耐药微生物的功效和药用动力学特征.
科学领域:
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
- 微生物学 微生物学
背景情况:
- 可纳是一种广泛使用的抗真菌剂,可以抑制14-α-兰醇脱甲基酶.
- 对醇抗真菌药物的耐药性增加,可能是由于酶基因突变,需要新的治疗策略.
研究的目的:
- 探索新型可纳衍生物的合成.
- 评估这些改性化合物对抗耐药真菌的生物活性和治疗潜力.
主要方法:
- 具有基,芳香和三醇环区域修改的可纳衍生物的化学合成.
- 生物研究,以评估合成化合物的疗效和药理动力学特性.
主要成果:
- 合成的可纳衍生物显示出增强抗真菌活性的潜力.
- 修改旨在克服现有的抗药机制并改善药物特性.
结论:
- 新型可纳衍生物为开发新的抗真菌疗法提供了有前途的途径.
- 对这些衍生物的进一步研究可能会导致改善对真菌感染的治疗方法.
更多相关视频
相关概念视频
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
2.9K
The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the...
2.9K
Drug Discovery: Overview
7.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.8K
Drug Biotransformation: Overview
2.4K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.4K
Structure-Activity Relationships and Drug Design
697
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
697
Drug Administration and Therapy Phases: Overview
446
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
446
Effects of Chemicals: Overview
1.2K
Drugs, encompassing various chemical compounds from natural sources, lab synthesis, or genetic engineering, elicit different biological responses in living organisms. Some of these responses are desirable or therapeutic, while others are undesirable. The primary goal of administering a drug is to achieve a therapeutic effect, that is, to address a specific disease or health condition. Any concurrent effects outside of this therapeutic outcome are considered undesirable. These undesirable...
1.2K


